An FDA document reveals that 86% of children between the ages of 12 and 15 who participated in Pfizer vaccine trials experienced adverse effects.

This troubling report, numbered 144413, only calls into question the use of the vaccine in children in that age range, approved on May 10 by the FDA, according to an FDA press release.

During the trials, 86% of the children had adverse reactions ranging from “mild” to “severe.”

The results of the controversial experimentation can be viewed publicly in the document.

Table 5 Study 2: Frequency and percentages of adolescents with solicited local reactions, by maximum severity, within 7 days after each dose – Adolescents aged 12 to 15 years.


As the table shows, there is a difference between the number of children who received the first dose of the 1127 vaccine and 1097 who received the second dose, calling into question what happened to these 30 children who did not show up for the second dose whether they withdrew from the trials or met an even worse fate.

The numbers shown by the trial were more than alarming. Even though 86% of the children suffered side effects after the first dose, the researchers continued experimenting and injected them with a second RNA vaccine.

Other data to note:

  • 65% of the children suffered headaches.
  • 66% of the children had a fever
  • About 44% of the children suffered “moderate” side effects, which they defined as “interfering with activity.”

They also suffered other side effects such as diarrhea, chills, joint pain, vomiting and muscle pain.

Despite all these conclusive data, the FDA deemed that the vaccine does not pose a danger to children and approved its emergency use.

In its press release, the FDA welcomes the expansion of vaccination to children between 12 and 15 years of age.

FDA Acting Commissioner Janet Woodcock expressed the importance of being able to inoculate adolescents.

“The FDA’s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,” he said.

He added that they are protecting a younger population to get back to “normal” as soon as possible and put an end to the pandemic.

He also said that “Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.”

This last statement does not seem to be in line with the reality of the results of the trials conducted, unless the FDA really thinks that 86% side effects are normal and they do not care at all about putting the lives of young people at risk, not to mention that there are also possible medium and long-term adverse effects that could be generated in those who receive this experimental RNA vaccine.